Skip to main content
. Author manuscript; available in PMC: 2021 Dec 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2020 Dec 1;85(4):450–453. doi: 10.1097/QAI.0000000000002483

TABLE 1.

Example Barriers and Interventions in TPT Scale-Up Among PLHIV in CDC-Supported Sites—Nigeria, 2018–2019

Section(s) of Tool Example Barrier Identified Example Intervention
Clinical training, community education, and patient management Clinician concerns about effectiveness of TPT, potential resistance to FNH, and TPT-related adverse events Sensitization of clinicians through direct mentorship and education sessions on benefits of TPT, effective TPT pretreatment counseling, management of adherence, and TPT-related adverse events
Community education Lack of TPT demand from patients Demand creation through convening patient education seminars in the waiting room on clinic days
Patient management Lack of clinician prescribing of TPT Periodic audit of all medical files of PLHIV seeking care to note eligibility for TPT
Periodic reviews of patient-level TPT form and site-level TPT register
Dissemination of TPT algorithms and job aids Use of a checklist to identify TPT eligibility, adverse events, and outcome
Commodities and logistics management Forecasting and ordering of INH for TPT based on historic use rather than planned scale-up Kitting of INH for each PLHIV initiating TPT to ensure supply
Linking TPT pickup with ART pickup to forecast numbers of TPT courses needed
Recording and reporting TPT initiations Inconsistent recording or use of nonstandard
indicators
Dissemination and training on correctly filling nationally standardized TPT monitoring and evaluation tools